|
NDRA Endra Life Sciences Inc 1681682 |
| Income Statement |
|
Net Income
|
endra_10q
|
-2,229,153 |
| Balance Sheet |
|
Current Assets
|
6,713,474 |
|
Assets
|
10,442,529 |
|
Current Liabilities
|
1,350,167 |
|
Liabilities
|
1,448,588 |
|
Equity
|
8,993,941 |
|
Shares Out
|
18,592,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-4,227,613 |
|
Investing Cash Flow
|
-12,796 |
| Market Analysis |
Market Cap
|
4,047,128 |
|
Price
|
6.01 |
|
BVPS
|
0.48 |
|
PB
|
12.51 |
|
EPS
|
-45.63 |
|
PS
|
10.40 |
|
FCF
|
-4,240,409 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NDRA documents filed with the SEC.
NDRA Filings
Clear
